The European Union’s drug regulator has given its backing to booster shots of the Pfizer-BioNTech Covid-19 vaccine for people aged 18 and older.
The European Medicines Agency said the booster doses “may be considered at least six months after the second dose for people aged 18 years and older”.
The agency’s human medicines committee issued the recommendation after studying data for the Pfizer vaccine that showed a rise in antibody levels following boosters given around six months after the second dose in people aged from 18 to 55.
The agency also said it supports giving a third dose of either the Pfizer-BioNTech or the Moderna vaccine to people with severely weakened immune systems at least 28 days after their second shot.
“Although there is no direct evidence that the ability to produce antibodies in these patients protected against Covid-19, it is expected that the extra dose would increase protection at least in some patients,” the agency said in a statement.
The recommendations go to health authorities in all 27 EU member states. Some countries already have begun administering booster shots.
Numerous studies have shown that the Pfizer-BioNTech and Moderna vaccines remain strongly protective months after people receive their second dose, dramatically cutting the risk of hospital admission and death.
The United States government launched a campaign last month to offer boosters of Pfizer’s vaccine to millions of Americans even as federal health officials stressed the real problem remains getting first shots to the unvaccinated.
The coronavirus pandemic has killed at least 4.8 million people around the world.
